Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Downloading Confusion: Are Mobile Drug Dose Calculators Medical Devices?

Executive Summary

Biopharmaceutical companies are expressing concern that a recent FDA draft guidance on mobile applications could force drug firms offering apps such as drug dose calculators to register and be regulated as medical device manufacturers.

You may also be interested in...



IOM Calls For More Government Oversight Of Health IT

The Institute of Medicine offers a series of recommendations to HHS to enhance the agency’s oversight of health IT, and calls on the private sector to be more engaged in sharing safety data with both the public and private sectors.

Industry Applauds FDA Draft Guidance On Mobile Medical Apps

The medical device and software industries voiced support last week for a July 19 FDA draft guidance that helps clarify the types of mobile software applications that would face FDA regulation.

FDA Social Media Group Reviewing Its First iPhone App As DTC Marketing Tool, But It's Not The First To Be Released

FDA has started wading into the iPhone business, at least to help determine how drug companies can use the App Store. FDA's social media working group is reviewing its first submission for an iPhone app as a direct-to-consumer marketing tool, Division of Drug Marketing, Advertising and Communications special assistant Jean-Ah Kang told the DTC National Conference April 9

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053886

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel